- Home
- SLRX vs CHSCL Comparison
SLRX vs CHSCL Comparison
Compare SLRX & CHSCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- CHSCL
- Stock Information
- Founded
- SLRX N/A
- CHSCL N/A
- Country
- SLRX United States
- CHSCL United States
- Employees
- SLRX N/A
- CHSCL N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- CHSCL Farming/Seeds/Milling
- Sector
- SLRX Health Care
- CHSCL Industrials
- Exchange
- SLRX Nasdaq
- CHSCL Nasdaq
- Market Cap
- SLRX 1.8M
- CHSCL N/A
- IPO Year
- SLRX N/A
- CHSCL N/A
- Fundamental
- Price
- SLRX $0.75
- CHSCL $25.48
- Analyst Decision
- SLRX
- CHSCL
- Analyst Count
- SLRX 0
- CHSCL 0
- Target Price
- SLRX N/A
- CHSCL N/A
- AVG Volume (30 Days)
- SLRX 3.6M
- CHSCL N/A
- Earning Date
- SLRX 08-08-2025
- CHSCL N/A
- Dividend Yield
- SLRX N/A
- CHSCL N/A
- EPS Growth
- SLRX N/A
- CHSCL N/A
- EPS
- SLRX N/A
- CHSCL N/A
- Revenue
- SLRX N/A
- CHSCL N/A
- Revenue This Year
- SLRX N/A
- CHSCL N/A
- Revenue Next Year
- SLRX N/A
- CHSCL N/A
- P/E Ratio
- SLRX N/A
- CHSCL N/A
- Revenue Growth
- SLRX N/A
- CHSCL N/A
- 52 Week Low
- SLRX $0.45
- CHSCL N/A
- 52 Week High
- SLRX $7.20
- CHSCL N/A
- Technical
- Relative Strength Index (RSI)
- SLRX 41.73
- CHSCL 46.40
- Support Level
- SLRX $0.66
- CHSCL $25.36
- Resistance Level
- SLRX $0.90
- CHSCL $25.58
- Average True Range (ATR)
- SLRX 0.12
- CHSCL 0.16
- MACD
- SLRX -0.03
- CHSCL 0.02
- Stochastic Oscillator
- SLRX 16.46
- CHSCL 68.75
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About CHSCL CHS Inc Class B Cumulative Redeemable Preferred Stock Series 4
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).